Minerva Neurosciences (NERV) – Trading Halts
-
Minerva Neurosciences (NERV) Receives CRL from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
-
Minerva Neurosciences (NERV) Halted, News Pending
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to NERV Stock Lookup